Abstract
Hemorrhagic shock is a life-threatening and time-sensitive condition that can be mitigated and reversed by a number of techniques including transfusions to replace blood loss and reverse anticoagulation, direct pressure and tourniquets to mechanically reduce blood loss, surgical techniques to directly close vessels and wounds, and hemostatic agents to reduce blood loss by improving coagulation of blood on tissue surfaces. In this chapter, we will discuss two of these methods that are easily learned and readily available for the advanced practice provider. Direct pressure and tourniquet placement are vital to extremity injury management to prevent blood loss. Central wounds and specific sites not able to be compressed are also amendable to hemostatic materials impregnated with pro-coagulant agents or directly bound to thrombin and/or fibrin to stimulate clot formation. These are often used for surgery and can be valuable adjuncts at the bedside in the emergency room, wards, and ICU.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mabry RL. Tourniquet use on the battlefield. Mil Med. 2006;171(5):352–6.
Richey SL. Tourniquets for the control of traumatic hemorrhage: a review of the literature. World J Emerg Surg. 2007;2:28.
Scerbo MH, Mumm JP, Gates K, et al. Safety and appropriateness of tourniquets in 105 civilians. Prehosp Emerg Care. 2016;20(6):712–22.
Holcomb JB, Butler FK, Rhee P. Hemorrhage control devices: tourniquets and hemostatic dressings. Bull Am Coll Surg. 2015;100(1 Suppl):66–70.
Noordin S, McEwen JA, Kragh JF Jr, Eisen A, Masri BA. Surgical tourniquets in orthopaedics. J Bone Joint Surg Am. 2009;91(12):2958–67.
Kragh JF Jr, Walters TJ, Baer DG, et al. Survival with emergency tourniquet use to stop bleeding in major limb trauma. Ann Surg. 2009;249(1):1–7.
Stop the bleed: Tourniquet application. PrepMedic, ed.
Trauma ACoSCo. The Hartford consensus: how to use a Tourniquet. YouTube; 2016.
Klein HO, Brodsky E, Ninio R, Kaplinsky E, Di Segni E. The effect of venous occlusion with tourniquets on peripheral blood pooling and ventricular function. Chest. 1993;103(2):521–7.
Asensio JA, McDuffie L, Petrone P, et al. Reliable variables in the exsanguinated patient which indicate damage control and predict outcome. Am J Surg. 2001;182(6):743–51.
Tompeck AJ, Gajdhar AUR, Dowling M, et al. A comprehensive review of topical hemostatic agents: the good, the bad, and the novel. J Trauma Acute Care Surg. 2020;88(1):e1–e21.
Boucher BA, Traub O. Achieving hemostasis in the surgical field. Pharmacotherapy. 2009;29(7 Pt 2):2S–7S.
Spotnitz WD. Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am Surg. 2012;78(12):1305–21.
Burks S, Spotnitz W. Safety and usability of hemostats, sealants, and adhesives. AORN J. 2014;100(2):160–76.
Kheirabadi B. Evaluation of topical hemostatic agents for combat wound treatment. US Army Med Dep J. 2011:25–37.
Grissom TE, Fang R. Topical hemostatic agents and dressings in the prehospital setting. Curr Opin Anaesthesiol. 2015;28(2):210–6.
Pereira BM, Bortoto JB, Fraga GP. Topical hemostatic agents in surgery: review and prospects. Rev Col Bras Cir. 2018;45(5):e1900.
Emilia M, Luca S, Francesca B, et al. Topical hemostatic agents in surgical practice. Transfus Apher Sci. 2011;45(3):305–11.
Gazzeri R, Galarza M, Alfier A. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures. Surg Technol Int. 2012;22:49–54.
Shander A, Kaplan LJ, Harris MT, et al. Topical hemostatic therapy in surgery: bridging the knowledge and practice gap. J Am Coll Surg. 2014;219(3):570–579.e574.
Spotnitz WD, Burks S. Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox. Transfusion. 2012;52(10):2243–55.
Mac DS, Matthews WH. Fibrin foam and Gelfoam in experimental kidney wounds. J Urol. 1947;57(5):802–11.
Sabel M, Stummer W. The use of local agents: Surgicel and Surgifoam. Eur Spine J. 2004;13(Suppl 1):S97–101.
Yu L, Gu T, Song L, et al. Fibrin sealant provides superior hemostasis for sternotomy compared with bone wax. Ann Thorac Surg. 2012;93(2):641–4.
Keshavarzi S, MacDougall M, Lulic D, Kasasbeh A, Levy M. Clinical experience with the Surgicel family of absorbable hemostats (oxidized regenerated cellulose) in neurosurgical applications: a review. Wounds. 2013;25(6):160–7.
Dhillon S. Fibrin sealant (evicel(R) [quixil(R)/crosseal]): a review of its use as supportive treatment for haemostasis in surgery. Drugs. 2011;71(14):1893–915.
Butts CA, Hagaman A, Porter J, Hazelton JP. Sutureless repair of a full-thickness cardiac stab wound adjacent to the right coronary artery using Evarrest(R) patch. Am Surg. 2019;85(8):e419–20.
Cox JM, Rall JM. Evaluation of XSTAT(R) and QuickClot(R) Combat Gauze(R) in a Swine Model of Lethal Junctional Hemorrhage in Coagulopathic Swine. J Spec Oper Med. 2017;17(3):64–7.
Motamedi MH, Sagafinia M. QuickClot combat gauze use for hemorrhage control in military trauma. Prehosp Disaster Med. 2011;26(3):237.
Basadonna G. QuikClot combat gauze for hemorrhage control. Prehosp Disaster Med. 2012;27(2):217.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mulkey, S.A., Surane, J., Ross, S.W. (2021). Tourniquet Application and Topical Hemostatics. In: Taylor, D.A., Sherry, S.P., Sing, R.F. (eds) Interventional Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-030-64661-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-64661-5_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-64660-8
Online ISBN: 978-3-030-64661-5
eBook Packages: MedicineMedicine (R0)